These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 7137357)

  • 1. Enrichment of bile with tauroursodeoxycholic acid and biliary cholesterol saturation in hamsters.
    Handelsman B; Bonorris G; Marks JW; Schoenfield LJ
    Am J Physiol; 1982 Nov; 243(5):G424-7. PubMed ID: 7137357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effects of ursodeoxycholic acid on the biliary lipids secretion (author's transl)].
    Yanaura S; Izuka A; Ishikawa S
    Nihon Yakurigaku Zasshi; 1981 Oct; 78(4):261-7. PubMed ID: 7327454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of tauroursodeoxycholate feeding, with or without taurine supplementation on hepatic bile acids and cholesterol metabolism in the hamster.
    Bellentani S; Bosisio E; Pecorari M; De Fabiani E; Cordoma P; Crestani M; Manenti F
    Pharmacol Res Commun; 1987 May; 19(5):327-39. PubMed ID: 3628457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of diet on bile acid kinetics and biliary lipid secretion in gallstone patients treated with ursodeoxycholic acid.
    Frenkiel PG; Lee DW; Cohen H; Gilmore CJ; Resser K; Bonorris GG; Marks JW; Schoenfield LJ
    Am J Clin Nutr; 1986 Feb; 43(2):239-50. PubMed ID: 3004189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intestinal absorption and biliary secretion of ursodeoxycholic acid and its taurine conjugate.
    Rudolph G; Kloeters-Plachky P; Sauer P; Stiehl A
    Eur J Clin Invest; 2002 Aug; 32(8):575-80. PubMed ID: 12190957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bile acids with a cyclopropyl-containing side chain. IV. Physicochemical and biological properties of the four diastereoisomers of 3 alpha,7 beta-dihydroxy-22,23-methylene-5 beta-cholan-24-oic acid.
    Roda A; Grigolo B; Aldini R; Simoni P; Pellicciari R; Natalini B; Balducci R
    J Lipid Res; 1987 Dec; 28(12):1384-97. PubMed ID: 3430066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bile acid glycine and taurine conjugates in serum of patients with primary biliary cirrhosis: effect of ursodeoxycholic treatment.
    Chretien Y; Poupon R; Gherardt MF; Chazouilleres O; Labbe D; Myara A; Trivin F
    Gut; 1989 Aug; 30(8):1110-5. PubMed ID: 2767508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of ursodeoxycholic acid on hepatic LDL binding and uptake in dietary hypercholesterolemic hamsters.
    Ceryak S; Bouscarel B; Malavolti M; Robins SJ; Caslow KL; Fromm H
    Atherosclerosis; 2000 Nov; 153(1):59-67. PubMed ID: 11058700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A combination of chenodeoxycholic acid and ursodeoxycholic acid is more effective than either alone in reducing biliary cholesterol saturation.
    Podda M; Zuin M; Dioguardi ML; Festorazzi S; Dioguardi N
    Hepatology; 1982; 2(3):334-9. PubMed ID: 7076116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Permeability of the rat biliary tree to ursodeoxycholic acid.
    Farges O; Corbic M; Dumont M; Maurice M; Erlinger S
    Am J Physiol; 1989 Apr; 256(4 Pt 1):G653-60. PubMed ID: 2705526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of ursodeoxycholic acid administration on biliary lipid secretion in primary biliary cirrhosis.
    Roda E; Mazzella G; Bazzoli F; Villanova N; Minutello A; Simoni P; Ronchi M; Poggi C; Festi D; Aldini R
    Dig Dis Sci; 1989 Dec; 34(12 Suppl):52S-58S. PubMed ID: 2598768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ursodeoxycholic acid is conjugated with taurine to promote secretin-stimulated biliary hydrocholeresis in the normal rat.
    Úriz M; Sáez E; Prieto J; Medina JF; Banales JM
    PLoS One; 2011; 6(12):e28717. PubMed ID: 22194894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conjugation is rate limiting in hepatic transport of ursodeoxycholate in the rat.
    Zouboulis-Vafiadis I; Dumont M; Erlinger S
    Am J Physiol; 1982 Sep; 243(3):G208-13. PubMed ID: 7114264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of ursodeoxycholic acid administration on bile acid composition in hamster bile.
    Matejka M; Vescina C; Carducci CN; Alayón A; Dios A; Scarlatto E; Mamianetti A
    Pharmacol Res; 1990; 22(3):297-305. PubMed ID: 2367280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Replacement of cholesterol gallstones by murideoxycholyl taurine gallstones in prairie dogs fed murideoxycholic acid.
    Cohen BI; Ayyad N; Mosbach EH; McSherry CK; Matoba N; Hofmann AF; Ton-Nu HT; Peng Y; Schteingart CD; Stenger RJ
    Hepatology; 1991 Jul; 14(1):158-68. PubMed ID: 2066064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of Na+ replacement and amiloride on ursodeoxycholic acid-stimulated choleresis and biliary bicarbonate secretion.
    Lake JR; Van Dyke RW; Scharschmidt BF
    Am J Physiol; 1987 Feb; 252(2 Pt 1):G163-9. PubMed ID: 3826345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 3alpha-6alpha-Dihydroxy-7alpha-fluoro-5beta-cholanoate (UPF-680), physicochemical and physiological properties of a new fluorinated bile acid that prevents 17alpha-ethynyl-estradiol-induced cholestasis in rats.
    Clerici C; Castellani D; Asciutti S; Pellicciari R; Setchell KD; O'Connell NC; Sadeghpour B; Camaioni E; Fiorucci S; Renga B; Nardi E; Sabatino G; Clementi M; Giuliano V; Baldoni M; Orlandi S; Mazzocchi A; Morelli A; Morelli O
    Toxicol Appl Pharmacol; 2006 Jul; 214(2):199-208. PubMed ID: 16487557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of tauroursodeoxycholic acid (TUDCA) on biliary lipid composition.
    Muraca M; Vilei MT; Cianci V; Liu XT
    Ital J Gastroenterol; 1995; 27(8):439-40. PubMed ID: 8775471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of tauroursodeoxycholic acid and taurine supplementation on biliary bile acid composition.
    Batta AK; Salen G; Shefer S; Tint GS; Dayal B
    Hepatology; 1982; 2(6):811-6. PubMed ID: 7141393
    [No Abstract]   [Full Text] [Related]  

  • 20. Comprehensive study of the biliary bile acid composition of patients with cystic fibrosis and associated liver disease before and after UDCA administration.
    Nakagawa M; Colombo C; Setchell KD
    Hepatology; 1990 Aug; 12(2):322-34. PubMed ID: 2391071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.